I have to say I missed the boat on IMU at 2.9c last year - I had no understanding of biotech back then and perhaps a moderately better understanding now.
I feel like IVX essentially becomes the listed front from which RMW commercialises Photosoft globally - IVX allows Cho to move from funding trials himself (which he has done completely so far, with some help from the IVX washing machine) to progressively out-licensing to IVX in broader jurisdictions as the treatment progressively generates clinical trial outcomes.
IVX Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)